UCLA Researchers Develop Low-Cost Blood Test to Detect Multiple Cancers And Other Diseases From a Single Sample

oncodaily - The new method analyzes genome-wide methylation of DNA circulating in the bloodstream to detect liver, lung, ovarian and stomach cancers, as well as several non-cancer conditions. UCLA scientists have developed […]

AI Summary: Researchers at UCLA introduced a low-cost blood test capable of detecting multiple cancers and other diseases from a single sample, promising broader screening reach and earlier detection. If validated at scale, the technology could lower barriers to multi-cancer screening, reshape diagnostic pathways, and offer cheaper, simpler surveillance—assuming the usual caveats about follow-up testing and false positives.


Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions

2 months / oncodaily

2 months / oncodaily

3 months / oncodaily

3 months / oncodaily


On location: early-detection debates, AI risk stratification and screening value

2 months / oncodaily

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily


On the ground: UCLA’s inexpensive blood test expands multi-disease detection

2 months / medicalxpress

2 months / oncodaily

3 months / oncodaily

3 months / medicalxpress


All Other Stories

2 months / nature

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / nature

2 months / oncodaily

2 months / oncodaily

2 months / medicalxpress





Related Stories


Countdown to Brachytherapy Awareness Day spotlights the specialty / 20 days

Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 3 months

National study to use genetic testing to guide cancer survivor follow-up / 2 months

Bowelbabe Fund reaches £20M and announces vaccine initiative / 3 months

Ultrasensitive HPV blood test detects head and neck recurrence months earlier / 29 days

Introducing ISCO 2026 chairs and program highlights / 2 months

Study links never-married status to higher cancer risk / 3 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Obesity, Drug Development, Venture Capital, Medicare Advantage (not listed) and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.